Evaluating the impact of lactase supplementation on infant colic: Study protocol for a systematic review of

Anna Kozłowska-Jalowska1, Agata Stróżyk1, Andrea Horvath1

  • 1Department of Pediatrics The Medical University of Warsaw Warsaw Poland.

JPGN Reports
|March 28, 2024
PubMed

Insights

Lactase supplementation may help manage infant colic, a common condition in newborns. This systematic review examines the effectiveness and safety of using lactase for infant colic relief.

Area of Science:

  • Pediatrics
  • Gastroenterology
  • Evidence-based Medicine

Background:

  • Infant colic is a prevalent functional gastrointestinal disorder in early infancy.
  • The exact causes of infant colic are not fully understood, but lactase deficiency is a potential contributing factor.
  • Current evidence on dietary interventions and lactase supplementation for infant colic is limited.

Purpose of the Study:

  • To systematically review the efficacy and safety of oral lactase supplementation for managing infant colic.
  • To synthesize findings from randomized controlled trials (RCTs) on lactase for infant colic.

Main Methods:

  • Systematic review of RCTs comparing oral lactase supplementation with placebo or no intervention.
  • Searches conducted in Cochrane CENTRAL, MEDLINE, and EMBASE for infants under 6 months with colic.
  • Risk of bias assessed using the Cochrane Collaboration's risk-of-bias tool (Version 2).

Main Results:

  • Primary outcome: number of responders (defined as reduced daily crying).
  • Secondary outcomes: crying duration/frequency, infant sleep, parental satisfaction, infant discomfort, hospital admissions, quality of life, and adverse events.
  • Data synthesis will focus on comparing lactase supplementation to control groups.

Conclusions:

  • The review will provide evidence on the effectiveness and safety of lactase supplementation for infant colic.
  • Findings will inform clinical practice and future research directions in managing infant colic.
  • Results will be disseminated through peer-reviewed publications and conference presentations.

Related Concept Videos

Drugs for Treatment of Constipation-Predominant IBS01:21

Drugs for Treatment of Constipation-Predominant IBS

Pharmacological therapies for IBS-C are designed to alleviate abdominal discomfort and enhance bowel function. In patients with IBS-C, fiber supplements may help soften stools and decrease straining, but may also lead to increased gas production and bloating. Osmotic laxatives like milk of magnesia are frequently used to soften stools and increase stool frequency in IBS-C patients. In addition, two drugs approved for use in severe IBS-C adult cases are linaclotide (Linzess) and lubiprostone...
162
Inflammatory Bowel Disease III: Diagnostic Studies and Management I-Nutritional Therapy01:30

Inflammatory Bowel Disease III: Diagnostic Studies and Management I-Nutritional Therapy

Various diagnostic tests are employed in the diagnostic process for Inflammatory Bowel Disease (IBD), particularly to differentiate between Crohn's disease and ulcerative colitis.
Diagnostic studies
A colonoscopy is the definitive screening test, distinguishing ulcerative colitis from other colon diseases with similar symptoms. During a colonoscopy test, inflamed mucosa with exudate ulcerations can be observed, and biopsies are taken to determine the histologic characteristics of the...
331
Drugs for Treatment of Diarrhea-Predominant IBS01:17

Drugs for Treatment of Diarrhea-Predominant IBS

Diarrhea-predominant irritable bowel syndrome (IBS-D) is a subtype of IBS characterized primarily by frequent, loose, or watery stools, abdominal pain, and abdominal discomfort. Therapeutic approaches to managing IBS-D include dietary changes, stress management techniques, and pharmaceutical interventions.
Two specific drugs used in the treatment are alosetron (Lotronex) and eluxadoline (Viberzi). Alosetron, a 5-HT3 antagonist, works by slowing the movement of stools in the gut, reducing bowel...
166